Events during March 2022

The course runs over four half-days, plus one optional additional Clinical Module on the following Monday. The course is suitable for those who are relatively new to flow cytometry and who wish to expand their experience with applications and specific analysis.

Veterinary microbiologists/biomedical scientists, infectious diseases specialists, epidemiologists, early career researchers, clinicians and academics interested in developing a better understanding of current and future diagnostic technologies, which can support clinical decision on antimicrobial treatment, therefore promoting antimicrobial stewardship.

In conversation with IBMS Chief Executive David Wells and Lorna Cleverly on animal health

Delivering science, celebrating achievement

Chair: Andrew Usher
13.00 Degree laboratory placement, the success of the symbiotic relationship
Dr Sue Jones and Dr Claire Wright, York St. John University
13.30 Supporting learning using a virtual environment
Dr Andrew Pember, Carina Consulting Ltd
14.00 Recognising and supporting the role of the laboratory trainers
Dr Mike Carter, Formerly Public Health England
14.30 Too busy to train?
Victoria Moyse, HCA Healthcare
15.45 Spotting qualification fraud
Adam Crosbie, Jisc
16.15 Qualification choices: HSD v MSc Chris Ward, Institute of Biomedical Science
16.45 Opening HSST to biomedical scientists
Dr Jane Needham, IBMS Council

13.00 ISO 15189 it’s all about the patient: What to expect from the new version
Dr David Ricketts, Health Services Laboratories LLP
13.30 Quality for the patient, not just for the sake of it
Shauna McAuley, Belfast Health and Social Care Trust
14.00 Learning from excellence – recognising when things go right Dr Adrian Plunkett, Learning from
Excellence, Birmingham Women’s and Children’s NHS Foundation Trust
14.30 Investigation of serious incidents
– what to do when things go wrong Nigel Coles, Birmingham Women’s and Children’s NHS Foundation Trust
15.45 Ensuring quality in an emergency situation
Jessica Dixon, Milton Keynes University Hospital NHS Foundation Trust
16.15 Maintaining a permanent state of readiness
John Ringrow, UKAS
16.45 Remote auditing
David Wilson, IBMS Specialist Advisor, Immunology

13.00 Introduction
Chantel Hodgson, UK NEQAS Cellular Pathology Technique
13.30 Upper and lower GI Christopher Irving, Gloucestershire Hospitals NHS Foundation Trust
14.15 Gynaecological case studies Kirstie Rice, Black Country Pathology Services, The Royal Wolverhampton Hospital Trust and Gary Player, University Hospital of North Durham
15.45 Skin case studies
Dr Guy Orchard, Viapath Analytics, An NHS Partnership with SYNLAB
16.15 Fluid, Respiratory, Urology case studies
Dr Behdad Shambayati, Berkshire and Surrey Pathology Services
16.45 Breast case studies
Patrick Kumah, University Hospitals of Derby and Burton NHS Foundation Trust

13.00 How the UK IVD industry responded to the pandemic
Lord Bethell
13.30 Pathology GIRFT: Next steps and implementing the recommendations Dr Martin Myers, Dr Marion Wood and Tom Lewis, NHS England and Improvement
14.00 Pathology Quality Assurance Dashboard: The Early years
Jane Mills & Bruce Daniel, NHS England and Improvement
14.30 Pathology Networks: maturity, future strategy & enablers
Jane Mills, NHS England and Improvement
15.45 Pathology Networks: Developing our people, strategy and planning
Bruce Daniel, Suchita Joshi & Divine Azange
16.15 The pathology portal
Professor Jo Martin, NHS England and Improvement

13.00 ISO 15189 it’s all about the patient: What to expect from the new version
Dr David Ricketts, Health Services Laboratories LLP
13.30 Quality for the patient, not just for the sake of it
Shauna McAuley, Belfast Health and Social Care Trust
14.00 Learning from excellence – recognising when things go right Dr Adrian Plunkett, Learning from
Excellence, Birmingham Women’s and Children’s NHS Foundation Trust
14.30 Investigation of serious incidents
– what to do when things go wrong Nigel Coles, Birmingham Women’s and Children’s NHS Foundation Trust
15.45 Ensuring quality in an emergency situation
Jessica Dixon, Milton Keynes University Hospital NHS Foundation Trust
16.15 Maintaining a permanent state of readiness
John Ringrow, UKAS
16.45 Remote auditing
David Wilson, IBMS Specialist Advisor, Immunology

Chair: Tony Dedman
9.00 Monitoring asparaginase activity to inform treatment of acute lymphoblastic leukaemia
Dr Jonathan Lambert, Great Ormond Street Hospital for Children NHS Foundation Trust
9.30 How will the challenges of the pandemic impact how we offer future Clinical Biochemistry services? Dr David Ricketts, Health Services Laboratories LLP
10.30 Harveys Gang: From the lab to the ward
Sophie Ward, NorthWest London Pathology, Charing Cross Hospital London
11.00 Spectrum of conditions associated with paraproteins: From laboratory to the clinic
Dr Aaron Niblock, Antrim Area Hospital, Northern Health and Social Care Trust 11.30 Cerebrospinal fluid (CSF) biomarkers in the investigation
of patients with dementia
Dr Alison Green, University of Edinburgh
12.45 Demand optimisation in a post- COVID world
Claire Lawrie, NHS National Services Scotland